153
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Antiadipogenic activity of isohamnetin 3-O-β-D-glucopyranoside from Salicornia herbacea

&
Pages 907-911 | Received 07 Feb 2012, Accepted 24 Feb 2012, Published online: 17 Sep 2012
 

Abstract

In the present study, effect of flavonoid glucopyranoside, isorhamnetin 3-О-β-D-glucopyranoside, from Salicornia herbacea on adipogenic differentiation were evaluated in 3T3-L1 adipocytes. Confluent 3T3-L1 preadipocytes in medium (0.5 mM methylisobutylxanthine, 0.25 µM dexamethasone, 5 µg/mL insulin, and 10% fetal bovine serum [FBS]) were differentiated into adipocytes for 6 days with/without isorhamnetin 3-О-β-D-glucopyranoside. The presence of isorhamnetin 3-О-β-D-glucopyranoside effectively suppressed adipogenic differentiation by downregulation of peroxisome proliferator-activated receptor-γ (PPARγ), CCAAT/enhancer-binding proteins (C/EBPα), sterol regulatory element-binding protein 1 (SREBP1), and the adipocyte-specific proteins. Moreover, the specific mechanism mediating the effects of isorhamnetin 3-О-β-D-glucopyranoside was confirmed by activation of AMP-activated protein kinase (AMPK). These findings suggest that isorhamnetin 3-О-β-D-glucopyranoside exerts antiadipogenic activity through AMPK activation. This study should find the nutraceutical value of S. herbacea-derived glucopyranoside, isorhamnetin 3-О-β-D-glucopyranoside, as potent candidate of antiobesity agent via alleviation of lipid accumulation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.